Estimated sales of major generic introductions in U.S. 2016

This statistic shows the estimated annual sales of major branded drugs that went generic in the United States during 2016. Allergy drug Nasonex (mometasone furoate monohydrate) generated annual sales of 956 million dollars in the United States in 2015. The first generic version of this drug was available on March 22, 2016.

Major generic introductions of branded drugs in the U.S. in 2016, by sales (in million US dollars)*

Brand (generic) nameSales in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2017

Region

United States

Survey time period

2016

Supplementary notes

* Sales are estimated 2015 U.S. sales.
** No data available.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.